ArticleGenetics2026
Statistical analysis of correlated expression data from high throughput experiments.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Data obtained from high throughput experiments often exhibit complex dependencies among features. These dependencies arise from various sources, including genetic correlation, batch effects, technical replicates, and shared biological pathways. Ignoring these dependencies can lead to inflated false discovery rate (FDR), reduced statistical power, and biased biological interpretations. Properly accounting for these dependencies is crucial for accurate detection of biological signals. We propose a new method called Analysis of Correlated Expressions (ACE) to compare the mean expression of features between two groups. ACE is based on a factor analytic model that accounts for dependence among features and also incorporates heterogeneity of variances between groups, a common feature of high throughput data. Furthermore, ACE does not require the data to be normally distributed. It is scalable and free of any unknown tuning parameters. Extensive simulation studies indicate that it is more powerful than many existing methods while controlling the FDR. Application of ACE to a microRNA dataset, a neuroblastoma gene expression dataset, and a Huntington's disease dataset resulted in some novel findings that were missed by existing methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.